Market Overview

UPDATE: Goldman Sachs Downgrades Cohen & Steers to Sell on Sector Challenges

Related CNS
Lazard (LAZ) Reflects Organic Growth: Time to Buy the Stock?
Earnings Scheduled For January 18, 2017

Goldman Sachs lowered its rating on Cohen & Steers (NYSE: CNS) from Hold to Buy and reduced its price target from $31 to $26.50.

Goldman Sachs noted, "We believe CNS shares will underperform (both absolute and relative) as investors contemplate: (1) growing “indexation” of real estate mutual funds amid gains from ETFs; (2) slipping 3-year performance numbers and slower open-end mutual fund flows; (3) recent dividend cuts in Japanese sub-advised funds driving outflows and an adverse fee mix shift. Still, CNS trades at 20X NTM P/E, a significant premium to the group's 14X, and we see 21% downside."

Cohen & Steers closed at $33.71 on Tuesday.

Latest Ratings for CNS

Oct 2016Keefe Bruyette & WoodsMaintainsMarket Perform
Jul 2016Credit SuisseInitiates Coverage onNeutral
Jul 2016Credit SuisseInitiates Coverage onNeutral

View More Analyst Ratings for CNS
View the Latest Analyst Ratings

Posted-In: Goldman SachsAnalyst Color Downgrades Pre-Market Outlook Analyst Ratings


Related Articles (CNS)

View Comments and Join the Discussion!

Partner Center